Competitive Clinical Research Grant
Eli Lilly's grant funds independent, investigator-led clinical research aligned with its therapeutic priorities, offering study drug and/or financial support to projects selected through a competitive review process.
This grant is no longer accepting proposals
Eli Lilly and Company has archived this opportunity.
Funder: Eli Lilly and Company
Due Dates (Anticipated): October 2026 (full proposal deadline)
Funding Amounts: Support varies; may include study drug and/or financial support for external investigator-initiated studies. Award size and duration not specified—dependent on project scope.
Summary: Funds independent, investigator-initiated clinical research aligned with Lilly’s therapeutic priorities, providing study drug and/or financial support via a competitive RFP process.
Key Information: Applicants are responsible for full conduct, design, and regulatory sponsorship of the study.
Description
The Competitive Clinical Research Grant program from Eli Lilly and Company supports external, investigator-initiated clinical studies that align with Lilly’s current research interests and therapeutic priorities. Through periodic Requests for Proposals (RFPs), Lilly invites independent researchers to submit proposals for studies that may receive support in the form of study drug, financial resources, or both. Proposals are reviewed by global committees of Lilly medical and scientific staff, and sometimes external experts, to ensure scientific merit and alignment with company priorities. Approved grantees retain responsibility for the full conduct, design, and regulatory sponsorship of their research.
